Many Questions Surround GRIFFIN Study

(MedPage Today) -- The phase II GRIFFIN study, presented at December's American Society of Hematology (ASH) virtual meeting, assessed the efficacy and safety of the addition of daratumumab into the lenalidomide, bortezomib, and dexamethasone (RVd...